Concomitant Valve Replacement and Coronary Artery Bypass Grafting Surgery: Lessons from the Past, Guidance for the Future? A Mortality Analysis in 294 Patients.
Kyriakos SpiliopoulosDimitrios E MagouliotisIlias AngelisIoannis SkoularigisBernhard M KemkesNikolaos S SalemisThanos AthanasiouBrigitte GanseraAndrew V XanthopoulosPublished in: Journal of clinical medicine (2023)
Hospital mortality (30 d) was nearly 2.5-fold higher in female and/or older than 70 y patients. Preoperative atrial fibrillation and/ or a calculated ES > 8 were independent predisposing factors of late mortality for combined VR and CABG surgery. Tailoring the approach, with the employment of the newest techniques and hybrid procedures, to the individual patient clinical profile enables favorable outcomes for concomitant valvular disease and CAD, especially in high-risk patients.
Keyphrases
- end stage renal disease
- coronary artery bypass grafting
- atrial fibrillation
- ejection fraction
- chronic kidney disease
- newly diagnosed
- healthcare
- peritoneal dialysis
- cardiovascular events
- emergency department
- prognostic factors
- type diabetes
- risk factors
- mitral valve
- physical activity
- venous thromboembolism
- aortic valve
- adipose tissue
- mental health
- mental illness
- transcatheter aortic valve replacement
- skeletal muscle
- insulin resistance
- middle aged
- left atrial appendage
- community dwelling
- direct oral anticoagulants